Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
Clinical trial NCT01698281 · TERMINATED
Trial details
- NCT number
- NCT01698281
- Sponsor
- AEterna Zentaris
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2014-08-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.